Ansy Patel, Deevyashali Parekh, Devashish Desai, Vishw Patel, Vedant Shah, Kesar Prajapati, Shivam Chetankumar Patel, Rahul Seth. "Sequencing in the post-immunotherapy era: Does second-line tyrosine kinase inhibitor choice impact survival and safety in advanced HCC?." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.4140